Biotricity Inc. (BTCY) vs SINTX TECHNOLOGIES, INC. (SINT)
Biotricity Inc. and SINTX TECHNOLOGIES, INC. are both Medical Devices companies. SINTX TECHNOLOGIES, INC. is the larger, with a market value of $12.5M against $10.9M — 1.1× the size. Biotricity Inc. grew revenue faster over the last twelve months: 13.4% against −28.5%. Biotricity Inc. has the higher net margin (−21.0% vs −1,423.0%) and the higher return on invested capital (0.00% vs −548.1%). Across the 17 metrics below, Biotricity Inc. leads on 15 and SINTX TECHNOLOGIES, INC. on 2.
Valuation
Profitability
| Metric | BTCY | SINT | Medical Devices median |
|---|---|---|---|
| Gross margin | 81.47% | 52.86% | 56.01% |
| Operating margin | 9.56% | (884.81%) | (15.03%) |
| Net margin | (21.00%) | (1,423.01%) | (20.40%) |
| Free cash flow margin | 0.99% | (777.14%) | (7.24%) |
| Return on equity | 9.75% | (429.26%) | (15.32%) |
| Return on assets | (57.12%) | (192.88%) | (19.72%) |
| Return on invested capital | 0.00% | (548.06%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack